News Releases
Keyword Search
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
Date Title  
04/09/18 Avid Bioservices to Participate at INTERPHEX 2018 Printer Friendly Version
03/22/18 Avid Bioservices Receives Six 2018 CMO Leadership Awards Printer Friendly Version
03/13/18 Avid Bioservices to Participate at Upcoming CDMO Industry Conferences Printer Friendly Version
03/12/18 Avid Bioservices Reports Financial Results for Third Quarter of Fiscal Year 2018 and Recent Developments Printer Friendly Version
03/07/18 Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock Printer Friendly Version
03/06/18 Avid Bioservices to Present at the 30th Annual ROTH Conference Printer Friendly Version
03/05/18 Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2018 After Market Close on March 12, 2018 Printer Friendly Version
03/01/18 Avid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture of Novel Alzheimer’s Disease Candidate Printer Friendly Version
02/26/18 Avid Bioservices Announces Resignation of Chief Financial Officer Printer Friendly Version
02/21/18 Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences Printer Friendly Version
02/20/18 Avid Bioservices Announces Closing of Public Offering of Common Stock Printer Friendly Version
02/15/18 Avid Bioservices Announces Pricing of Public Offering of Common Stock Printer Friendly Version
02/14/18 Avid Bioservices Announces Proposed Offering of Common Stock Printer Friendly Version
02/12/18 Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including Bavituximab Printer Friendly Version
01/23/18 Avid Bioservices to Present at NobleCon14 Printer Friendly Version